REFERENCES
  1. Jaeken J, Péanne R. What is new in CDG? J Inherit Metab Dis. 2017; 40:569-586.
  2. Altassan R, Witters P, Saifudeen Z, et al. Renal involvement in PMM2-CDG, a mini-review. Mol Genet Metab. 2018;123:292-296.
  3. Wang CS, Greenbaum LA. Nephrotic syndrome. Pediatr Clin North Am. 2019;66:73-85.
  4. Hutchesson ACJ, Gray RGF, Spencer DA, Keir G. Carbohydrate deficient glycoprotein syndrome; multiple abnormalities and diagnostic delay. Arch Dis Child. 1995; 72: 445-446.
  5. van der Knaap MS, Wevers RA, Monnens L, Jakobs C, Jaeken J, van Wijk JAE. Congenital nephrotic syndrome: a novel phenotype of type I carbohydrate-deficient glycoprotein syndrome.J Inherit Metab Dis. 1996;19:787-791.
  6. Jamroz E, Adamek D, Paprocka J, Adamowicz M, Marszal E, Wevers RA. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions. J Child Neurol. 2009;24:13-18.
  7. Schiff M, Roda C, Monin M-L, et al. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature. J Med Genet. 2017;54:843-851.
  8. Jaeken J, Stibler H, Hagberg B. Clinical presentation and natural course of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand. 1991; Suppl. 375:6-13.